Who invested in COUR Pharma

One round we have observed, with the 8 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 4 months ago

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2026, from 2 sources

Latest round: Series B, $50MJun 2026
Led by: Roche Venture Fund and Lumira Ventures
Investors: 8 (2 led)

See who backed them

The rounds

Jun 2026
Series B$50M
Reported by Lumira Ventures and 1 other

Founders and team

From COUR Pharma's own website: 1 founder, 8 on the team.

John J. PuisisFounder, Former President and CEO

Dannielle AppelhansPresident and CEO
Brian C. BockChief Financial Officer
Sarah LongoriaChief People Officer
Fred HenryExecutive Director, Head of Regulatory Affairs
Lori JesterVP, Technical Operations
Noelia RycerzVP, Development Operations
Robert F. CareyLead Independent Director
Simon GreenwoodRoche Venture Fund Senior Investment Director

Everyone who backed them

Roche Venture FundCorporate VC1round, led 1

Lumira VenturesVC firm1round, led 1

SanofiInvestment firm1round

PfizerCorporate VC1round

Alpha Wave GlobalPrivate equity1round

Angelini VenturesVC firm1round

Alpha Wave VenturesVC firm1round

T1D Fund: A Breakthrough T1D VentureVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists COUR Pharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

T1D FundCorporate VCPer its own site

Quick answers about COUR Pharma

Who invested in COUR Pharma?

COUR Pharma's investors include Roche Venture Fund, Lumira Ventures, Sanofi, Pfizer and Alpha Wave Global, and 3 more on record. Roche Venture Fund led its latest round.